Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment N Kotur, J Lazic, B Ristivojevic, B Stankovic, V Gasic, L Dokmanovic, ... Genes 11 (4), 468, 2020 | 26 | 2020 |
Genome-wide association study of COVID-19 outcomes reveals novel host genetic risk loci in the Serbian population M Zecevic, N Kotur, B Ristivojevic, V Gasic, V Skodric-Trifunovic, ... Frontiers in Genetics, 1793, 0 | 13 | |
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations B Stanković, N Kotur, V Gašić, K Klaassen, B Ristivojević, M Stojiljković, ... Journal of medical biochemistry 39 (4), 488, 2020 | 12 | 2020 |
Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients J Komazec, B Ristivojevic, B Zukic, V Zdravkovic, T Karan-Djurasevic, ... Molecular Biology Reports 47 (9), 6759-6768, 2020 | 3 | 2020 |
Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients? M Jelovac, N Kotur, B Ristivojevic, D Pavlovic, V Spasovski, N Damjanov, ... International Journal of Molecular Sciences 24 (10), 8538, 2023 | 1 | 2023 |
Farmakogenetički markeri odgovora na terapiju tiopurinskim lekovima, metotreksatom i vinkristinom kod dece sa akutnom limfoblastnom leukemijom BM Ristivojević Univerzitet u Beogradu-Biološki fakultet, 2023 | | 2023 |
The pharmacogenomics of vincristine-induced peripheral neuropathy in pediatric acute lymphoblastic leukemia patients in Serbia-a single center experience B Ristivojević, N Kotur, B Stanković, V Gašić, J Lazić, S Pavlović, B Zukić Srpski arhiv za celokupno lekarstvo, 99-99, 2021 | | 2021 |